We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
-12.49%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$48.6B
AUM Growth
-$4.2B
Cap. Flow
+$3.6B
Cap. Flow %
7.4%
Top 10 Hldgs %
10.29%
Holding
4,108
New
835
Increased
964
Reduced
740
Closed
743

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$340M
2
BAC icon
Bank of America
BAC
+$302M
3
CI icon
Cigna
CI
+$294M
4
TSM icon
TSMC
TSM
+$275M
5
UNP icon
Union Pacific
UNP
+$256M

Top Sells

Rank Stock Value
1
VZ icon
Verizon
VZ
+$426M
2
SPGI icon
S&P Global
SPGI
+$413M
3
BKNG icon
Booking.com
BKNG
+$264M
4
CMCSA icon
Comcast
CMCSA
+$256M
5
TFX icon
Teleflex
TFX
+$241M

Sector Composition

Rank Sector Weight
1 Healthcare 17.59%
2 Financials 16.96%
3 Technology 16.37%
4 Consumer Discretionary 9.33%
5 Industrials 7.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LYRA
3276
DELISTED
LYRA THERAPEUTICS INC
LYRA
$74K ﹤0.01%
+259
New +$70.5K
PHAS
3277
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$73K ﹤0.01%
123,039
-98,444
-44% -$94.3K
LFT
3278
Lument Finance Trust
LFT
$41.9M
$72K ﹤0.01%
30,315
-19,644
-39% -$50.6K
SCOR icon
3279
Comscore
SCOR
$72K ﹤0.01%
+1,772
New +$73.7K
SMSI icon
3280
Smith Micro Software
SMSI
$14M
$71K ﹤0.01%
+728
New +$84.6K
FEZ icon
3281
PUT
State Street SPDR EURO STOXX 50 ETF
FEZ
$4.28B
$69K ﹤0.01%
+2,000
New +$76.3K
PRVB
3282
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$69K ﹤0.01%
+17,108
New +$81.1K
EPIX
3283
DELISTED
ESSA Pharma
EPIX
$67K ﹤0.01%
+21,393
New +$120K
CIFRW
3284
CALL
DELISTED
Cipher Mining Warrant
CIFRW
$66K ﹤0.01%
48,720
NU icon
3285
Nu Holdings
NU
$68.1B
$66K ﹤0.01%
+17,649
New +$89.5K
AAOI icon
3286
Applied Optoelectronics
AAOI
$8.04B
$64K ﹤0.01%
+40,960
New +$100K
BEST
3287
DELISTED
BEST Inc. American Depositary Shares, each representing twenty (20) Class A Ordinary Shares
BEST
$64K ﹤0.01%
14,103
+13,145
+1,372% +$92.3K
CMPX icon
3288
Compass Therapeutics
CMPX
$373M
$63K ﹤0.01%
+23,727
New +$51.5K
UPH.WS
3289
CALL
DELISTED
UpHealth, Inc. Warrants exercisable for one share of Common Stock at an exercise price of $115.00 per share
UPH.WS
$63K ﹤0.01%
110,395
SMED
3290
DELISTED
Sharps Compliance Corp
SMED
$61K ﹤0.01%
+20,600
New +$86K
LTCH
3291
DELISTED
Latch, Inc. Common Stock
LTCH
$60K ﹤0.01%
+53,700
New +$137K
EGHT icon
3292
8x8 Inc
EGHT
$247M
$59K ﹤0.01%
11,521
-712,415
-98% -$5.96M
DAO
3293
Youdao
DAO
$1.85B
$58K ﹤0.01%
+11,395
New +$68K
FXB icon
3294
Invesco CurrencyShares British Pound Sterling Trust
FXB
$76.9M
$58K ﹤0.01%
+500
New +$60.3K
HOUR icon
3295
Hour Loop
HOUR
$65.8M
$58K ﹤0.01%
+22,977
New +$73.2K
SKIL icon
3296
Skillsoft
SKIL
$56.9M
$58K ﹤0.01%
835
-56
-6% -$5.78K
ANNX icon
3297
Annexon
ANNX
$855M
$56K ﹤0.01%
14,961
-13,211
-47% -$40.4K
BLZE icon
3298
Backblaze
BLZE
$697M
$56K ﹤0.01%
10,798
-31,558
-75% -$237K
ZVIA icon
3299
Zevia
ZVIA
$108M
$55K ﹤0.01%
19,579
-179,807
-90% -$557K
FSRDW
3300
CALL
DELISTED
Fast Radius, Inc. Warrants
FSRDW
$55K ﹤0.01%
89,200
-200,779
-69% -$18.6K

Similar funds

Marshall Wace's Q2 2022 Portfolio in Review

As of Q2 2022, Marshall Wace held 4,108 positions worth $48.6B, down 8% from $52.8B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Marshall Wace deployed $3.6B of net new capital in Q2 2022, opening 835 new positions and adding to 964 existing holdings. Its largest new stake was Eli Lilly: 1,133,393 shares worth $367M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Verizon, an estimated $426M trimmed.

  • Marshall Wace's largest Q2 2022 buy was Eli Lilly: 1,133,393 shares worth $367M.
  • Marshall Wace added most to Bank of America in Q2 2022, an estimated $302M increase.
  • Marshall Wace's biggest Q2 2022 reduction was Verizon, cutting an estimated $426M.
  • Marshall Wace fully exited Teleflex in Q2 2022, selling an estimated $241M.
  • Marshall Wace's ten largest holdings make up 10% of its $48.6B portfolio in Q2 2022.
  • Marshall Wace opened 835 new positions and closed 743 in Q2 2022.
  • Marshall Wace's portfolio value fell 8% quarter-over-quarter to $48.6B.

Based on Marshall Wace's 13F filing for Q2 2022, filed 15 Aug 2022.